Getting rare disease drugs past the brain’s self-defence
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Getting rare disease drugs past the brain’s self-defence
Pharmacies can stand out in the TikTok Shop supplements market
Four realities reshaping HCP engagement strategies
Jelena Mann is Professor of Epigenetics at Newcastle Uni
Who monitors AI medical devices following authorisation?
Should pharma comms stop trying to make science ‘simple’?
Fifth member of The Smiths attempts to write a chorus
Diabetes care tech has transformed now access must